The goal of this proposal is to define the role that Bcl-2 expression (a gene that inhibits apoptosis or programmed cell death) plays in mucous cell metaplasia (MCM). MCM is the appearance of mucous secretory cells in regions of the respiratory tract normally devoid of these cells induced by exposure to bacterial endotoxins. Endotoxin exposure has been implicated in transient and chronic lung function impairment after exposure to organic dusts in cotton mills, poultry houses, swine confinement buildings, and saw mills. Pulmonary infections resulting from endotoxin-laden gram-negative bacteria are characterized by an influx of inflammatory cells and increased production and secretion of respiratory mucus. Both conditions are believed to be important factors in the pathogenesis of obstructive pulmonary disorders, such as asthma, chronic bronchitis and cystic fibrosis. The increased responsiveness of asthmatic individuals to endotoxin exposure may involve prolonged retention of the metaplastic mucous cells. Bcl-2 expression is found in metaplastic mucous cells induced by endotoxin exposure in rat pulmonary airways and in patients suffering from chronic obstructive pulmonary disease. Therefore, we will test the hypotheses that Bcl-2 plays a key role in prolonging the retention of metaplastic mucous cells in airway epithelia. An established rodent model of mucous cell metaplasia will be used (1) to determine which components of lavage fluid, harvested from endotoxin-instilled rats, enhance Bcl-2 expression and mucous cell metaplasia and (2) to define the role of Bcl-2 in the initiation and maintenance of mucous cell metaplasia by directly inhibiting Bcl-2 expression in endotoxin-induced MCM in vitro and in vivo using anti-sense oligonucleotides to Bcl-2. The modulation of Bcl-2 gene expression will help to clarify how endotoxin induces MCM and could form the basis for studies to identify other key factors in the apoptotic signaling pathway, including the surface receptors for the induction of Bcl-2. This information will contribute to the development of new gene-directed therapeutic strategies for controlling overproduction and hypersecretion of mucus in individuals with chronic respiratory diseases associated with mucous cell metaplasia.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES009237-03
Application #
6382249
Study Section
Lung Biology and Pathology Study Section (LBPA)
Program Officer
Packenham, Joan P
Project Start
1999-09-01
Project End
2004-08-31
Budget Start
2001-09-01
Budget End
2002-08-31
Support Year
3
Fiscal Year
2001
Total Cost
$355,320
Indirect Cost
Name
Lovelace Biomedical & Environmental Research
Department
Type
DUNS #
045911138
City
Albuquerque
State
NM
Country
United States
Zip Code
87108
Chand, Hitendra S; Montano, Gilbert; Huang, Xuesong et al. (2014) A genetic variant of p53 restricts the mucous secretory phenotype by regulating SPDEF and Bcl-2 expression. Nat Commun 5:5567
Chand, Hitendra S; Harris, Jennifer Foster; Mebratu, Yohannes et al. (2012) Intracellular insulin-like growth factor-1 induces Bcl-2 expression in airway epithelial cells. J Immunol 188:4581-9
Smith, Kevin R; Leonard, David; McDonald, Jacob D et al. (2011) Inflammation, mucous cell metaplasia, and Bcl-2 expression in response to inhaled lipopolysaccharide aerosol and effect of rolipram. Toxicol Appl Pharmacol 253:253-60
Mebratu, Yohannes A; Dickey, Burton F; Evans, Chris et al. (2008) The BH3-only protein Bik/Blk/Nbk inhibits nuclear translocation of activated ERK1/2 to mediate IFNgamma-induced cell death. J Cell Biol 183:429-39
Xiang, Jialing; Rir-Sim-Ah, Jules; Tesfaigzi, Yohannes (2008) IL-9 and IL-13 induce mucous cell metaplasia that is reduced by IFN-gamma in a Bax-mediated pathway. Am J Respir Cell Mol Biol 38:310-7
Bredow, Sebastian; Juri, Daniel E; Cardon, Karen et al. (2007) Identification of a novel Bcl-2 promoter region that counteracts in a p53-dependent manner the inhibitory P2 region. Gene 404:110-6
Stout, Barbara A; Melendez, Karla; Seagrave, JeanClare et al. (2007) STAT1 activation causes translocation of Bax to the endoplasmic reticulum during the resolution of airway mucous cell hyperplasia by IFN-gamma. J Immunol 178:8107-16
Harris, J Foster; Aden, Jay; Lyons, C Rick et al. (2007) Resolution of LPS-induced airway inflammation and goblet cell hyperplasia is independent of IL-18. Respir Res 8:24
Bartner, Lisa R; Robinson, N Edward; Kiupel, Matti et al. (2006) Persistent mucus accumulation: a consequence of delayed bronchial mucous cell apoptosis in RAO-affected horses? Am J Physiol Lung Cell Mol Physiol 291:L602-9
Tesfaigzi, Yohannes (2006) Roles of apoptosis in airway epithelia. Am J Respir Cell Mol Biol 34:537-47

Showing the most recent 10 out of 22 publications